Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Osteosarcoma 3Neuroblastoma 3Sarcoma, Ewing 2Rhabdomyosarcoma 2With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer 1Stomach Neoplasms 1Sarcoma, Synovial 1Sarcoma, Clear Cell 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Rhabdoid Tumor 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroectodermal Tumors, Primitive 1Nerve Sheath Neoplasms 1Myoepithelioma 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Hodgkin Disease 1Giant Cell Tumor of Bone 1Desmoplastic Small Round Cell Tumor 1Chordoma 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Ascites 1Adenocarcinoma 1

Interventions

Indocyanine Green 2gentamicin-polymethylmethacrylate bead 1Zoledronic Acid 1Transurethral Resection of Bladder 1Surgical Procedures, Operative 1Methods 1Amputation, Surgical 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Giant Cell Tumor of Bone × Zoledronic Acid × Clear all
NCT03295981 2026-04-22

Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone

St. Louis University

Phase 3 Recruiting
120 enrolled

Giant Cell Tumor of Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡